麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Rural Health Payout
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Cosmetic Surgery
  • Gavin Newsom
  • RFK Jr.
  • Medicaid Work Requirements

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, May 17 2019

Full Issue

OxyContin Maker Faces Fresh Round Of Lawsuits From 5 More States Over Opioid Epidemic

Kansas, Iowa, Maryland, Pennsylvania, West Virginia and Wisconsin filed suits this week against Purdue Pharma for the drug manufacturer's alleged role in the national opioid epidemic.

Five more state attorneys general announced legal filings Thursday seeking to hold the company that makes OxyContin responsible for an opioid addiction crisis that's now the leading cause of accidental deaths across the country and in many states. The company, Connecticut-based Purdue Pharma, blasted the claims, saying they're based on "stunningly overbroad legal theories, which if adopted by courts, will undermine the bedrock legal principle of causation." (Izaguirre and Mulvihill, 5/16)

The lawsuits were announced six days after a North Dakota judge dismissed that state's lawsuit accusing Purdue Pharma of overstating the benefits and trivializing the addiction risks of prolonged opioid use. North Dakota is expected to appeal. Purdue Pharma called the new lawsuits "misleading attacks," and said it will defend itself against them. (Stempel, 5/16)

鈥淓ven when it became apparent that thousands of people were dying of opioid abuse, Purdue doubled down by continuing its relentless and deceptive campaign鈥 to persuade doctors to write prescriptions for OxyContin, Morrisey said. Maryland Attorney General Brian Frosh said his state鈥檚 efforts were based on 鈥渢wo foundational falsehoods鈥 that Purdue promoted widely: That the risk of becoming addicted to Purdue鈥檚 drug was very low and that under-treating pain could cause great harm. (Bernstein, 5/16)

Prescription opioid overdoses killed 217,530 people in the U.S. from 1999 to 2017, according to the Centers for Disease Control and Prevention. Total opioid-related deaths in that period reached nearly 400,000. A Purdue spokesman on Thursday denied the new allegations, calling them 鈥渟tunningly overbroad legal theories.鈥 He said the lawsuits 鈥渁re part of a continuing effort to try these cases in the court of public opinion rather than the justice system.鈥 All told, 44 states and another 1,700 local municipalities and Native American tribes have brought claims against the makers and distributors of prescription opioids. (Randazzo, 5/16)

The makers of the powerful and addictive painkiller OxyContin used deceptive marketing to persuade doctors to prescribe the opioid that contributed to a national epidemic of addiction, a lawsuit filed by Wisconsin Attorney General Josh Kaul alleges. Wisconsin is one of a handful of states that filed lawsuits this week alleging Purdue Pharma and Richard Sackler 鈥 creators of the drug 鈥 peddled false information to downplay the risky side effects of using OxyContin to kill pain and inflated the drug's benefits. (Beck, 5/16)

Purdue Pharma LP and its billionaire owners are being sued by five more states alleging the company鈥檚 aggressive marketing of the OxyContin painkiller triggered a vast addiction epidemic that has claimed hundreds of thousands of lives in the U.S. The attorneys general of Maryland, Wisconsin, Iowa, West Virginia and Kansas announced the latest suits on Thursday in a joint statement. Filed by both Republicans and Democrats, the complaints add to a wave of litigation accusing Purdue and the Sackler family, which owns the company, of knowingly pushing doctors to prescribe OxyContin even for minor pain. (Larson and Feeley, 5/16)

In other news on the national drug crisis聽鈥

State officials in Texas and Louisiana have launched multiple probes into the Cenikor Foundation following an investigation by Reveal that found the prominent drug rehab has turned patients into an unpaid labor force for private companies. Reveal from The Center for Investigative Reporting found that the nonprofit has sent thousands of patients to work without pay at hundreds of for-profit companies over the years 鈥 including Exxon, Shell and Walmart 鈥 in likely violation of federal labor law, according to former federal labor officials. (Walter, 5/16)

Exactly half of Massachusetts voters support the idea of opening supervised consumption sites in the state. A WBUR poll found 43 percent oppose such clinics, where drug use is monitored to prevent or reverse an overdose. And 8% of 660 adults (topline results, crosstabs) declined to respond or were undecided. (Bebinger, 5/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
  • Tuesday, April 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优